Peer Review History: An Overview of FDA Approved Liposome Formulations for Cancer Therapy

Editor(s):

(1) Dr. Erich Cosmi, University of Padua, Italy.

Reviewers:

(1) Amol B Deore, MVP Samaj’s Institute of Pharmaceutical Sciences, India.

(2) Muhsin Konuk, Üsküdar University, Turkey.

Additional Reviewers:

(1) Alberto Rodriguez-Archill, University of Granada, Spain.

(2) AVS Suresh, Continental Hospitals, India.

(3) Ebru Derici Eker, Mersin University Health Science Institute, Turkey.

(4) Shweta Gupta, University of Mumbai, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Amol B Deore, India) | File 1 | NA


Stage 2 | Peer review report_2 (Muhsin Konuk, Turkey) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Posted in Review History.